This page is not the official website. Generated by AI, does not constitute any advice. If needed, please click here to visit the corresponding official website.
Dongcheng Pharmaceutical Group (Stock Code: 002675) – vertically integrated producer of pharmaceutical-grade biochemical raw materials, serving over 40 countries with GMP-certified quality and full traceability.
Dongcheng Pharmaceutical was founded in 1998 and went public in 2012. As the first Chinese supplier of heparin sodium to pass the MFDS GMP audit by the Korea Food & Drug Administration and the PMDA GMP on-site inspection by Japan, we set the benchmark for quality and compliance.
We hold GMP certificates from BGV (Germany), CFDA (China), and the CEP certificate from EDQM in Europe. Our products comply with both the European Pharmacopoeia and United States Pharmacopeia standards.
Specializing in four major fields: Biochemical Raw Materials, Chemical Drugs, Chinese Patent Medicine, and Nuclear Drugs.
Leader in the heparin industry with full vertical integration, ensuring quality and traceability from raw material to API.
Largest domestic producer of chondroitin sulfate in China, supplying pharmaceutical and dietary supplement grades globally.
Expanding into health supplements including Chondroitin Glucosamine Capsules for joint health and wellness.
High-purity, GMP-compliant active pharmaceutical ingredients trusted by global partners in over 40 countries.
Pharmaceutical-grade anticoagulant API compliant with USP and Ph. Eur. standards.
Low molecular weight heparin used in thrombosis prevention and treatment.
LMWH with high anti-Xa activity, suitable for subcutaneous injection.
Anticoagulant with extended half-life, ideal for long-term therapy.
Highly purified LMWH with consistent batch-to-batch quality.
Alternative salt form of heparin for specific formulation needs.
Pharmaceutical and supplement grade for joint health applications.
Calcium salt variant with enhanced stability in certain formulations.
Dual-action supplement for osteoarthritis and joint mobility support.
High-purity intermediates and APIs for downstream pharmaceutical use.
Small molecule APIs developed under strict GMP conditions.
Emerging focus area in radiopharmaceuticals and diagnostic agents.
Certified by MFDS (Korea), PMDA (Japan), BGV (Germany), and CFDA (China).
Full control from sourcing to production ensures traceability and quality.
Trusted by partners across Europe, America, Asia, and the Middle East.
We hold GMP certificates from MFDS (Korea), PMDA (Japan), BGV (Germany), and CFDA (China), as well as the CEP certificate from EDQM in Europe.
Our products are exported to more than 40 countries across Europe, North and South America, Asia, and the Middle East.
We focus on four areas: Biochemical Raw Materials, Chemical Drugs, Chinese Patent Medicine, and Nuclear Drugs, with core expertise in heparin and chondroitin APIs.
Yes, Dongcheng Pharmaceutical Group is listed on the stock exchange with the code 002675.
For inquiries, partnerships, or product information, visit our official website to contact the DCB Group team.
Notice for Buyers: If you are a buyer, the above information is generated by AI collection and does not constitute any advice. If necessary, please visit the corresponding official website.
For Domain Owners: If you are the domain owner and do not want to be included by fobcompany.info, please contact support@fobcompany.info via your corporate email to cancel. We will cancel your inclusion within 3 business days.
如果您是域名所有者 不想被fobcompany.info收录 请用企业邮箱联系support@fobcompany.info 取消收录 我们将在3个工作日取消您的收录
Service Request: If you are other domain and want to be included, please contact support@fobcompany.info
如果您是其他域名合作 也请联系support@fobcompany.info